Related Experiment Video
Updated: May 2, 2026

10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
2.5K
Cell cycle, oncogenic and tumor suppressor pathways regulate numerous long and macro non-protein-coding RNAs
Genome Biology
|March 6, 2014
Summary
Most cellular transcription is non-coding. New research reveals that pathway activation generates abundant long non-coding RNAs (lncRNAs), suggesting their functional importance beyond random events.
Area of Science:
- Genomics
- Molecular Biology
- RNA Biology
Background:
- The mammalian genome is pervasively transcribed, producing many non-protein-coding RNAs.
- Assessing the functionality of long non-coding RNAs (lncRNAs) is complex.
- Differential gene expression is key to understanding protein function and disease.
Purpose of the Study:
- To systematically identify lncRNAs differentially expressed in response to oncological and cell-cycle pathways.
- To investigate the functional significance of non-coding transcripts.
Main Methods:
- Utilized tiling arrays to identify differentially expressed lncRNAs.
- Analyzed pathway-specific transcriptional responses.
- Examined evolutionary conservation and secondary structure of macroRNAs.
Main Results:
- Up to 80% of pathway-triggered transcription involves non-coding RNAs, including large macroRNAs.
- MacroRNAs show pathway-specific expression, conserved elements, and secondary structures.
- Differential macroRNA expression was observed in astrocytoma, suggesting a role in disease.
Conclusions:
- Signaling pathways induce a substantial amount of non-coding RNA expression.
- The prevalence of non-coding transcripts is unlikely due to random transcription.
- Findings highlight the functional relevance of lncRNAs in cellular processes and disease.
Related Concept Videos
lncRNA - Long Non-coding RNAs
7.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K
lncRNA - Long Non-coding RNAs
2.6K
2.6K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression
1.5K
1.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Cancer-Critical Genes II: Tumor Suppressor Genes
2.6K
2.6K

